GABAPENTIN
- Product NDC
- 67296-1745
- 11-digit product format
- 672961745
- Labeler code
- 67296
- Product ID
- 67296-1745_a30a26b5-2379-38b5-e053-2a95a90ad99e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RedPharm Drug, Inc.
- Application
- ANDA205101
- Marketing category
- ANDA
- Marketing start
- 2016-11-20
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 800 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67296-1745-6 | GABAPENTIN | 60 in 1 BOTTLE | TABLET | 60 | | 9 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67296-1745 | GABAPENTIN TABLET [REDPHARM DRUG, INC.] | 9 | Legacy NDC, 1 package rows | 20200414_a30a2645-75a9-dcd9-e053-2995a90a58e7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67296-1745-6 | 67296174506 | 60 TABLET in 1 BOTTLE (67296-1745-6) | 60 tablet | 2020-01-01 | 0000-00-00 | No | No | Current |